emtricitabine-tenofovir on HealthSpring Assurance Rx (S5617-215)
generic Truvada
Covered.
Tier 4 (non-preferred drug). Quantity limit of 30 per 30 days.
$259.15
Patient pays / month, after deductible
$683.50
Patient pays / month, before the $615.00 deductible
$777.46
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 200/300 mg Tablet, Film Coated at a preferred retail pharmacy, from the plan's negotiated price of $835.98 for a month. Other covered strengths are listed below.
All 4 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 200/300 mg Tablet, Film Coated | 4 | $259.15 | 30 per 30 days |
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 100/150 mg Tablet, Film Coated | 4 | $260.49 | 30 per 30 days |
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 133/200 mg Tablet, Film Coated | 5 | $213.27 | 30 per 30 days |
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 167/250 mg Tablet, Film Coated | 4 | $264.48 | 30 per 30 days |
Other HIV drugs on this plan
Verify with the plan before prescribing or filling. Member services: (800)222-6700. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5617-215